Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

License Revoked From Shanghai Hualian Pharmaceutical Factory

January 7, 2008
-
Health

The Shanghai Municipal Drug and Food Administration has revoked the Drug Production License of Shanghai Hualian Pharmaceutical Factory, which allegedly sickened over a hundred leukemia patients who took doses of the company's Methotrexate and Cytarabine medicines.

In addition, SMDFA has confiscated all of the factory's illegal income from the sales of these medicines. And the police have detained the managers who were found hiding information when the government was investigating their products. A special work team has been set up to handle compensation for the victims.

Under the guidance of and with the participation of a joint investigation team set up between the Ministry of Health and State Drug and Food Administration, concerned departments in Shanghai identified the cause of the accident: Hualian's staff mixed Vincristine Sulfate into Methotrexate for injection and Cytarabine for injection, and this caused damage to the drugs and made them unqualified and unusable.

Readers also read this:

XCMG Machinery Releases ESG Report

August 14, 2024

Norwegian Agri CEO Makes Green Visit To China

June 1, 2024

Sino-French Dairy Cooperation Takes Flight

May 15, 2024

China Construction Bank Signs ESG Platform Deal In Singapore

April 30, 2024

Inaugural One Earth Summit Concludes In Hong Kong

March 28, 2024

United Nations Global Compact Welcomes Latest Chinese Company

February 8, 2024
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2026 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network